Bryan A Wee1, Mark Thomas2, Emma Louise Sweeney1, Francesca D Frentiu1, Melanie Samios3, Jacques Ravel4, Pawel Gajer4, Garry Myers5, Peter Timms6, John A Allan7,8, Wilhelmina M Huston1,2,8. 1. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia. 2. School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW, Australia. 3. School of Medicine, Griffith University and UC Health Clinical School, The Wesley Hospital, Brisbane, Qld, Australia. 4. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA. 5. ithree institute, University of Technology Sydney, Sydney, NSW, Australia. 6. Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Qld, Australia. 7. UC Health Clinical School, The Wesley Hospital, Brisbane, Qld, Australia. 8. Wesley Medical Research, The Wesley Hospital, Brisbane, Qld, Australia.
Abstract
BACKGROUND: We know very little about the microbiota inhabiting the upper female reproductive tract and how it impacts on fertility. AIMS: This pilot study aimed to examine the vaginal, cervical and endometrial microbiota for women with a history of infertility compared to women with a history of fertility. MATERIALS AND METHODS: Using a retrospective case-control study design, women were recruited for collection of vaginal, cervical and endometrial samples. The microbiota composition was analysed by 16S ribosomal RNA (rRNA) gene amplification and endometrial expression of selected human genes by quantitative reverse transcription polymerase chain reaction. RESULTS: Sixty-five specimens from the reproductive tract of 31 women were successfully analysed using 16S rRNA gene amplicon sequencing (16 controls and 15 cases). The dominant microbial community members were consistent in the vagina and cervix, and generally consistent with the endometrium although the relative proportions varied. We detected three major microbiota clusters that did not group by tissue location or case-control status. There was a trend that infertile women more often had Ureaplasma in the vagina and Gardnerella in the cervix. Testing for the expression of selected genes in the endometrium did not show evidence of correlation with case-control status, or with microbial community composition, although Tenascin-C expression correlated with a history of miscarriage. CONCLUSIONS: There is a need for further exploration of the endometrial microbiota, and how the microbiota members or profile interplays with fertility or assisted reproductive technologies.
BACKGROUND: We know very little about the microbiota inhabiting the upper female reproductive tract and how it impacts on fertility. AIMS: This pilot study aimed to examine the vaginal, cervical and endometrial microbiota for women with a history of infertility compared to women with a history of fertility. MATERIALS AND METHODS: Using a retrospective case-control study design, women were recruited for collection of vaginal, cervical and endometrial samples. The microbiota composition was analysed by 16S ribosomal RNA (rRNA) gene amplification and endometrial expression of selected human genes by quantitative reverse transcription polymerase chain reaction. RESULTS: Sixty-five specimens from the reproductive tract of 31 women were successfully analysed using 16S rRNA gene amplicon sequencing (16 controls and 15 cases). The dominant microbial community members were consistent in the vagina and cervix, and generally consistent with the endometrium although the relative proportions varied. We detected three major microbiota clusters that did not group by tissue location or case-control status. There was a trend that infertile women more often had Ureaplasma in the vagina and Gardnerella in the cervix. Testing for the expression of selected genes in the endometrium did not show evidence of correlation with case-control status, or with microbial community composition, although Tenascin-C expression correlated with a history of miscarriage. CONCLUSIONS: There is a need for further exploration of the endometrial microbiota, and how the microbiota members or profile interplays with fertility or assisted reproductive technologies.
Authors: Lela K Keburiya; Veronika Yu Smolnikova; Tatiana V Priputnevich; Vera V Muravieva; Alexey B Gordeev; Dmitry Yu Trofimov; Ekaterina S Shubina; Taisiya O Kochetkova; Margarita S Rogacheva; Elena A Kalinina; Gennady T Sukhikh Journal: BMC Womens Health Date: 2022-05-14 Impact factor: 2.742
Authors: Hilary O D Critchley; Elnur Babayev; Serdar E Bulun; Sandy Clark; Iolanda Garcia-Grau; Peter K Gregersen; Aoife Kilcoyne; Ji-Yong Julie Kim; Missy Lavender; Erica E Marsh; Kristen A Matteson; Jacqueline A Maybin; Christine N Metz; Inmaculada Moreno; Kami Silk; Marni Sommer; Carlos Simon; Ridhi Tariyal; Hugh S Taylor; Günter P Wagner; Linda G Griffith Journal: Am J Obstet Gynecol Date: 2020-07-21 Impact factor: 10.693
Authors: Madeline E Graham; William G Herbert; Stephanie D Song; Harshini N Raman; Jade E Zhu; Paulina E Gonzalez; Marina R S Walther-António; Marc J Tetel Journal: Trends Endocrinol Metab Date: 2021-05-25 Impact factor: 10.586
Authors: Nerea M Molina; Alberto Sola-Leyva; Maria Jose Saez-Lara; Julio Plaza-Diaz; Aleksandra Tubić-Pavlović; Barbara Romero; Ana Clavero; Juan Mozas-Moreno; Juan Fontes; Signe Altmäe Journal: Biomolecules Date: 2020-04-11